PET-CT评分用于恶性胸腔积液诊断的建立与验证
该研究基于18F-FDG PET-CT参数建立了一个用于鉴别恶性胸腔积液(MPE)与良性胸腔积液的评分系统,并在前瞻性衍生队列(84例恶性、115例良性)中开发、在独立前瞻性验证队列(n=74)中验证。评分以4分为截断值时,衍生队列的AUC为0.949(95%CI: 0.908-0.975),敏感度83.3%、特异度92.2%。结论认为该简便评分有助于临床鉴别MPE与良性胸腔积液。
要点
- PET-CT评分由5项参数组成:单侧肺结节/肿块伴18F-FDG摄取增高(3分)、肺外恶性肿瘤(3分)、胸膜增厚伴18F-FDG摄取增高(2分)、多发结节/肿块伴18F-FDG摄取增高(1分)、胸腔积液18F-FDG摄取增高(1分)。
- 以4分为截断值,衍生队列诊断MPE的AUC为0.949(95%CI: 0.908-0.975),敏感度83.3%(73.6%-90.6%),特异度92.2%(85.7%-96.4%)。
- 阳性似然比10.7(5.6-20.1),阴性似然比0.2(0.1-0.3),评分已在独立前瞻性队列(n=74)中验证。
核心结论
- 基于PET-CT参数的简易评分可帮助医生鉴别恶性胸腔积液与良性胸腔积液,并已在独立前瞻性队列中完成验证。
研究设计与样本
- 前瞻性衍生队列纳入胸腔积液患者(84例恶性、115例良性),用于开发PET-CT评分。
- 另设独立前瞻性验证队列(n=74)对评分进行验证。
主要发现
- 衍生队列中,PET-CT评分诊断MPE的AUC为0.949(95%CI: 0.908-0.975)。
- 以4分为截断值,敏感度为83.3%(73.6%-90.6%),特异度为92.2%(85.7%-96.4%)。
- 阳性似然比为10.7(5.6-20.1),阴性似然比为0.2(0.1-0.3)。
关键数值与推荐
- 评分参数及分值:单侧肺结节和/或肿块伴18F-FDG摄取增高计3分;肺外恶性肿瘤计3分;胸膜增厚伴18F-FDG摄取增高计2分;多发结节或肿块(单侧或双侧肺)伴18F-FDG摄取增高计1分;胸腔积液18F-FDG摄取增高计1分。
- 诊断截断值为4分。
临床怎么用
- 临床可依据上述5项PET-CT参数计算评分,以4分为截断值辅助鉴别恶性与良性胸腔积液。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although some parameters of positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG) and computed tomography (PET-CT) are somehow helpful in differentiating malignant pleural effusion (MPE) from benign effusions, no individual parameter offers sufficient evidence for its implementation in the clinical practice. The aim of this study was to establish the diagnostic accuracy of a scoring system based on PET-CT (the PET-CT score) in diagnosing MPE. METHODS: One prospective derivation cohort of patients with pleural effusions (84 malignant and 115 benign) was used to develop the PET-CT score for the differential diagnosis of malignant pleural effusion. The PET-CT score was then validated in another independent prospective cohort (n = 74). RESULTS: The PET-CT parameters developed for discriminating MPE included unilateral lung nodules and/or masses with increased 18F-FDG uptake (3 points); extrapulmonary malignancies (3 points); pleural thickening with increased 18F-FDG uptake (2 points); multiple nodules or masses (uni- or bilateral lungs) with increased 18F-FDG uptake (1 point); and increased pleural effusion 18F-FDG uptake (1 point). With a cut-off value of 4 points in the derivation cohort, the area under the curve, sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of the PET-CT score to diagnose MPE were 0.949 (95% CI: 0.908-0.975), 83.3% (73.6%-90.6%), 92.2% (85.7%-96.4%), 10.7 (5.6-20.1), and 0.2 (0.1-0.3), respectively. CONCLUSIONS: A simple-to-use PET-CT score that uses PET-CT parameters was developed and validated. The PET-CT score can help physicians to differentiate MPE from benign pleural effusions.
引用
- Yang MF, Tong ZH, Wang Z, et al. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion. Eur J Nucl Med Mol Imaging. 2019. PMID: 30903197. doi:10.1007/s00259-019-04287-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。